Possible therapy in hereditary angioneurotic edema (HAE).
D000799:Angioedema / Q000188:drug therapy*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D003169:Complement Inactivator Proteins; D003165:Complement System Proteins / Q000032:analysis; D004950:Esterases / Q000037:antagonists & inhibitors; D005174:Factor XII / Q000032:analysis / Q000037:antagonists & inhibitors; D006801:Humans; D005779:Immunodiffusion; D010958:Plasminogen / Q000032:analysis; D013498:Suramin / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D003169:Complement Inactivator Proteins; D013498:Suramin; D005174:Factor XII; D010958:Plasminogen; D003165:Complement System Proteins; D004950:Esterases